Refractory post-herpetic neuralgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: According to the Expert Consensus of Diagnosis and Treatment of Postherpetic Neuralgia in China (2016) and the Expert Consensus of Diagnosis and Treatment of Herpes Zoster in China (2022) the diagnostic criteria of PHN are as follows: (1) There is a clear history of herpes zoster and pain remains after the characteristic skin lesions subside and lasts for one month or more.
Exclusion criteria
Exclusion criteria: (1) lactating or pregnant women; (2) Patients with malignant tumor immune mental or serious diseases such as heart liver kidney and brain or abnormal coagulation function; (3) Those who have received other relevant treatments; (4) Patients with other serious complications of herpes zoster or other skin diseases; (5) Refusing to sign the informed consent; (6) Participated in other clinical studies in the past six months and the results of this study may be evaluated as disruptor by the researchers or they plan to participate in other clinical researchers during their participation in this study; (Note: Patients who meet any one of the above items will be excluded. )
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visualanaloguescal; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety state score;Pittsburgh sleep quality index score;Infrared thermal imaging;Depressive state score; | — |
Countries
China
Contacts
Chengdu Third People's Hospital